Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.
复制标题
DOI：
10.1007/s10147-015-0801-z
复制
发表时间：
2015-04
影响因子：
3.3
通讯作者：
Japanese Society for Cancer of the Colon and Rectum
中科院分区：
文献类型：
--
作者：
Watanabe T;Itabashi M;Shimada Y;Tanaka S;Ito Y;Ajioka Y;Hamaguchi T;Hyodo I;Igarashi M;Ishida H;Ishihara S;Ishiguro M;Kanemitsu Y;Kokudo N;Muro K;Ochiai A;Oguchi M;Ohkura Y;Saito Y;Sakai Y;Ueno H;Yoshino T;Boku N;Fujimori T;Koinuma N;Morita T;Nishimura G;Sakata Y;Takahashi K;Tsuruta O;Yamaguchi T;Yoshida M;Yamaguchi N;Kotake K;Sugihara K;Japanese Society for Cancer of the Colon and Rectum
结直肠癌是日本的一个主要死亡原因，在日本，结直肠癌是女性恶性肿瘤死亡人数最多的疾病，在男性中占第三位。近几十年来，已经开发了许多新的治疗方法。2014年日本结肠直肠癌学会指南用于治疗结直肠癌（JSCCR指南2014）已被编制为结直肠癌的标准治疗策略，以消除机构之间的治疗差异，消除不必要的治疗和治疗不足，并通过向公众提供这些准则，加深保健专业人员和病人之间的相互了解。这些指南是根据JSCCR指南委员会在仔细审查文献检索检索到的证据并考虑到日本医疗健康保险制度和实际临床实践的基础上达成的共识编写的。因此，它们可以在临床实践中用作治疗结直肠癌的指导。更具体地说，它们可用作获得患者知情同意和为每位患者选择治疗方法的指南。作为指南委员会讨论的结果，选择有争议的问题作为临床问题，并提出建议。每项建议都附有证据分类和建议类别分类，这些分类是根据指导原则委员会成员达成的共识。在这里，我们介绍了2014年JSCCR指南的英文版本。
Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms among women and the third largest number among men. Many new methods of treatment have been developed during recent decades. The Japanese Society for Cancer of the Colon and Rectum Guidelines 2014 for treatment of colorectal cancer (JSCCR Guidelines 2014) have been prepared as standard treatment strategies for colorectal cancer, to eliminate treatment disparities among institutions, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding among health-care professionals and patients by making these guidelines available to the general public. These guidelines have been prepared as a result of consensuses reached by the JSCCR Guideline Committee on the basis of careful review of evidence retrieved by literature searches and taking into consideration the medical health insurance system and actual clinical practice in Japan. They can, therefore, be used as a guide for treating colorectal cancer in clinical practice. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. As a result of the discussions of the Guideline Committee, controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories, on the basis of consensus reached by Guideline Committee members. Here we present the English version of the JSCCR Guidelines 2014.